Abstract:Despite advances in surgical and reperfusion therapy, there is no effective therapy currently exists to prevent the progressive decline in cardiac function following myocardial infarction. Hepatocyte growth factor has potent angiogenic and anti-apoptotic activities. The aim of this study was to investigate the therapeutic effect and dose-effect relationship on postinfarction heart failure with different doses of adenovirus-mediated human hepatocyte growth factor (Ad(5)-HGF) transference in swine models. Totally twenty swine were randomly divided into four groups: (a) control group (null- Ad(5), 1 ml); (b) low-dose group (1 x 10(9) Pfu/ml Ad(5)-HGF, 1 ml); (c) medium-dose group (5 x 10(9) Pfu/ml Ad(5)-HGF, 1 ml); (d) high-dose group (1 x 10(10) Pfu/ml Ad(5)-HGF, 1 ml). Four weeks after left anterior descending coronary artery (LAD) ligation, different doses of Ad(5)-HGF were transferred in three therapeutic groups via right coronary artery. Four and seven weeks after LAD ligation, gate cardiac perfusion imaging was performed to evaluate cardiac perfusion and left ventricular ejection fraction (LVEF). Seven weeks after surgery, the apoptotic index of cardiocyte was observed by TUNEL, the expression of Bcl-2, Bax, alpha-SMA and Factor VIII in the border zones were evaluated by immunohistochemistry, respectively. Four weeks after myocardial infarction, no significant difference was observed among four groups. Three weeks after Ad(5)-HGF transfer, the improvement of cardiac perfusion and LVEF was obviously observed, especially after 1 x 10(10) Pfu Ad(5)-HGF transfer. TUNEL assay showed that 5 x 10(9) Pfu and 1 x 10(10) Pfu Ad(5)-HGF treatment had a obvious reduction in the apoptotic index compared with the null-Ad(5) group, especially after 1 x 10(10) Pfu Ad(5)-HGF treatment. The expression of Bcl-2 protein was increased and the expression of Bax protein was inhibited in the 5 x 10(9) Pfu and 1 x 10(10) Pfu Ad(5)-HGF groups compared with the null-Ad(5) group. The vessel density of Factor VIII(+) and alpha-SMA(+) was increased in Ad(5)-HGF groups compared with the null-Ad(5) group. There were no significant differences in angiogenesis, reducing apoptosis and ameliorating heart function between the 1 x 10(9) Pfu Ad(5)-HGF group and the null-Ad(5) group. Although no statistical difference was observed between 1 x 10(10) Pfu and 5 x 10(9) Pfu Ad(5)-HGF groups, the cardiac protective effects of 1 x 10(10) Pfu Ad(5)-HGF treatment were greater than 5 x 10(9) Pfu Ad(5)-HGF treatment. Different doses of Ad5-HGF injected via noninfarct-related artery could induce angiogenesis, reduce apoptosis and ameliorate heart function, and the cardiac protective effects of 1 x 10(10) Pfu Ad5-HGF is of most significance.

Effect of Exogenous HGF Gene Transfection on Pulmonary Perfusion and Pressure in Pulmonary Artery Hypertension in Rabbits

In Vivo Transfection of Hepatocyte Growth Factor Gene Induces Pulmonary Angiogenesis in Rabbits with Hyperkinetic Pulmonary Hypertension

[Effect of VEGF Gene Transfer on the Bleomycin-Induced Pulmonary Hypertension in Immature Rabbits].

Gene Transfer of Vascular Endothelial Growth Factor Reduces Bleomycin-Induced Pulmonary Hypertension in Immature Rabbits.

Transfection of Human Hepatocyte Growth Factor Gene Inhibits Advancing Pulmonary Arterial Hypertension Induced by Shunt Flow in a Rabbit Model.

Recombinant human hepatocyte growth factor transfection alleviates hyperkinetic pulmonary artery hypertension in rabbit models

VEGFmRNA and Enosmrna Expression in Immature Rabbits with Bleomycin-Induced Pulmonary Hypertension.

Ultrasound-mediated HGF Gene Microbubbles Mitigate Hyperkinetic Pulmonary Arterial Hypertension in Rabbits

Induction of Collateral Artery Growth and Improvement of Post-Infarct Heart Function by Hepatocyte Growth Factor Gene Transfer

Enos Gene Transfection on Pulmonary Artery Hypertension and Hypertension Crisis in Rabbits

HGF Reduces Disease Severity and Inflammation by Attenuating the NF-κB Signaling in a Rat Model of Pulmonary Artery Hypertension

Combined Hypoxia Inducible Factor-1Α and Homogeneous Endothelial Progenitor Cell Therapy Attenuates Shunt Flow–induced Pulmonary Arterial Hypertension in Rabbits

Human Basic Fibroblast Growth Factor Gene Transfer Induces Angiogenesis in Ischemic Heart

Improvement of Heart Function in Postinfarct Heart Failure Swine Models after Hepatocyte Growth Factor Gene Transfer: Comparison of Low-, Medium- and High-Dose Groups

Evaluation of therapeutic effect of Ad-HGF gene modified PMSCs on limb ischemia in rabbit model

Gene transfer of endothelial nitric oxide synthase attenuates flow-induced pulmonary hypertension in rabbits.

Dual Pigment Epithelium-derived Factor and Hepatocyte Growth Factor Overexpression: A New Therapy for Pulmonary Hypertension.

[Effect of platelet-derived growth factor-BB on pulmonary vascular remodeling in neonatal rats with hypoxic pulmonary hypertension and its mechanism]

Dual PEDF and HGF Overexpression: A New Therapy for Pulmonary Hypertension

Recruitment of Stem Cells by Hepatocyte Growth Factor Via Intracoronary Gene Transfection in the Postinfarction Heart Failure

Changes in expression of hepatocyte growth factor and c-met in lungs in a rat model of pulmonary hypertension